Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States.

This study provides a contemporary assessment of the treatment patterns, health care resource utilization (HRU) and costs among metastatic castration-sensitive prostate cancer (mCSPC) patients in the U.